Sonnet BioTherapeutics Holdings, Inc. (SONN) Financials
Stock symbol SONN is outdated, potentially delisted? Maybe it is available on other exchange?
SONN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 5.8 million | 3.2 million |
| March 31, 2024 | 5.9 million | 2.9 million |
| Dec. 31, 2023 | 5.3 million | 2.8 million |
| Sept. 30, 2023 | 5.4 million | 5.7 million |
SONN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -3.1 million | 60395 |
| March 31, 2024 | 723792 | 60395 |
| Dec. 31, 2023 | -3.1 million | 50005 |
| Sept. 30, 2023 | -4.7 million | 50006 |
SONN Net Income
No data available :(
SONN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 3.6 million | 68837 | 150186 |
| March 31, 2024 | 3.8 million | 90446 | 168939 |
| Dec. 31, 2023 | 3.0 million | 110956 | 186686 |
| Sept. 30, 2023 | 2.3 million | 130863 | 203911 |
SONN Shares Outstanding
SONN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | 12000 | 1.7 million | 1.8 million | - |
| March 31, 2024 | - | 2.1 million | 1.7 million | - |
| Dec. 31, 2023 | - | 624068 | 653455 | - |
| Sept. 30, 2023 | 170000 | 1.8 million | 1.8 million | - |
SONN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | - | 21039 |
| March 31, 2024 | - | 20496 |
| Dec. 31, 2023 | 18626 | 19974 |
| Sept. 30, 2023 | 37255 | 19466 |
SONN Revenue by Segment
Graph available only for paid members. Upgrade to see it.
SONN
Price: $3.10
52 week price:
Earnings Per Share: -6.82 USD
P/E Ratio: -0.18
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 442053
Market Capitalization: 8.4 million